The effects of low-level direct current therapy on a preclinical mammary carcinoma: tumour regression and systemic biochemical sequelae.
AffiliationPaterson Institute for Cancer Research, Christie Hospital (NHS) Trust, Manchester, UK.
MetadataShow full item record
AbstractLow-level direct electric current has been shown to be capable of destroying tumour tissue. Using an early-passage subcutaneous murine mammary carcinoma, the relationships between the volume of tumour destruction, charge and polarity have been examined. The results revealed a direct correlation between charge passed and absolute volume regression when the intratumoral electrode was made either an anode or a cathode. Tumour destruction for a given charge was significantly greater following anodic than cathodic treatment. A direct correlation was also observed between the percentage volume of prompt treatment-induced regression and the in situ end point of tumour growth delay. During the course of these experiments, a highly reproducible toxic effect was discovered, which has not been previously reported for this modality. An anodic charge greater than 10.6 coulombs or a cathodic charge greater than 21.6 coulombs resulted in 100% mortality at 24-72 h, while lower charges had no influence on mortality. Quantitative assays of a number of blood parameters showed that mortality was associated with serum electrolyte imbalances and appeared to be the result of the metabolic load of tumour breakdown products. These effects are similar to the tumour lysis or surgical crush syndromes and should not constitute a significant problem in clinical practice, where the tumour mass to total body mass ratio will normally be much smaller.
CitationThe effects of low-level direct current therapy on a preclinical mammary carcinoma: tumour regression and systemic biochemical sequelae. 1994, 69 (5):875-8 Br. J. Cancer
JournalBritish Journal of Cancer
- Antitumor effectiveness of different amounts of electrical charge in Ehrlich and fibrosarcoma Sa-37 tumors.
- Authors: Ciria HC, Quevedo MS, Cabrales LB, Bruzón RP, Salas MF, Pena OG, González TR, López DS, Flores JM
- Issue date: 2004 Nov 26
- Low-level direct electrical current therapy for hepatic metastases. I. Preclinical studies on normal liver.
- Authors: Griffin DT, Dodd NJ, Zhao S, Pullan BR, Moore JV
- Issue date: 1995 Jul
- Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis.
- Authors: Hardee ME, Kirkpatrick JP, Shan S, Snyder SA, Vujaskovic Z, Rabbani ZN, Dewhirst MW, Blackwell KL
- Issue date: 2005 Dec 12
- Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning.
- Authors: Myerson RJ, Singh AK, Bigott HM, Cha B, Engelbach JA, Kim J, Lamoreaux WT, Moros E, Novak P, Sharp TL, Straube W, Welch MJ, Xu M
- Issue date: 2006 Mar
- Preclinical evaluation of DISC-GMCSF for the treatment of breast carcinoma.
- Authors: Loudon PT, McLean CS, Martin G, Curry J, Leigh Shaw M, Hoogstraten C, Verdegaal E, Osanto S
- Issue date: 2003 May